Worst Case Scenario Managing Side Effects | Attention Deficit Hyperactivity Disorder | Statin

Please download to get full document.

View again

of 18
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Information Report
Category:

Documents

Published:

Views: 7 | Pages: 18

Extension: PDF | Download: 0

Share
Related documents
Description
q
Transcript
  DIFFICULT CASES: CRACKING THE CODE: WORST “CASE” SCENARIO:MANAGING SIDE EFFECTSSATURDAY/3:15-4:15PM ACPE UAN:  0107-9999-16-039-L01-P 0.1 CEU/1 hr Activity Type: Application-Based Learning Objectives for Pharmacists: Upon completion of this CPE activity participants should be able to: 1. Discuss the prevalence of medication-related side effects2. Describe the mechanism by which select medication-related side effects occur 3. Review strategies for optimal management of medication-related side effects through a case-based approach4. Identify alternate treatment options for a patient who experiences a medication-related side effect Speaker: Michelle Bottenberg, PharmD, BCPS Michelle Bottenberg is an Associate Professor of Pharmacy Practice in the Department of Clinical Sciences at Drake University College of Pharmacy and Health Sciences in Des Moines, Iowa. She serves as the Director of the Pharmacy Skills and Applications course series and is currently the co-chair of the Des Moines Area Interprofessional Education Collaborative Planning Committee. Her primary areas of interest include interprofessional education, using simulation as an educational pedagogy, and scholarship of teaching and learning. After graduating from Drake University in 2005, Michelle completed a PGY-1 pharmacy practice residency with an emphasis in internal medicine at Iowa Methodist Medical Center in Des Moines. She earned her Board Certi fi cation in Pharmacotherapy (BCPS) in 2007. She is a member of IPA, AACP, ACCP, and the Rho Chi Honor Society, for which she currently serves as the Alpha Sigma Chapter faculty advisor at Drake. Michelle lives in Waukee, IA, with her husband Charlie, their three kids, Liam, Alaina, and Landon, and two beagles, Ajax and Violet. Speaker Disclosure:  Michelle Bottenberg reports no actual or potential con fl icts of interest in relation to this CPE activity. Off-label use of medications will not be discussed during this presentation. FEBRUARY 13, 2016 |  IOWA EVENTS CENTER |  DES MOINES, IOWA   1 Michelle M. Bottenberg, PharmD, BCPS  Associate Professor of Pharmacy PracticeDrake University College of Pharmacy and Health Sciences Worst-“Case” Scenario: Managing Medication-related Side Effects ã Michelle M. Bottenberg reports no actual or potential conflicts of interest associated with this presentation Disclosure  2 ã Upon successful completion of this activity, pharmacists should be able to: ã Discuss the prevalence of medication-related side effects ã Discuss the mechanism by which select medication-related side effects occur  ã Review strategies for optimal management of medication-related side effects through a case-based approach ã Identify alternate treatment options for a patient who experiences a medication-related side effect Learning Objectives ã  Any substance that is capable of generating a therapeutic effect can also yield unwanted or adverse effects ã  Adverse drug reaction (ADR): ã  An appreciably harmful or unpleasant reaction , resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment , or alteration of the dosage regimen , or withdrawal of the product 1 ã Tens of millions of people in the US use prescription & OTC medications 2 ã Institute of Medicine (IOM) estimates at least 1.5 million preventable ADR effects occur within the healthcare system each year  3 Medication-related Side Effects 1 Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet . 2000; 356: 1255–59 2 FDA’s Safe Use Initiative. http://www.fda.gov/downloads/Drugs/Drug Safety/UCM188961.pdf (accessed January 17, 2016) 3 Institute of Medicine 2007. Preventing Medication Errors. Washington, DC: The National Academies Press.  3 ã In 2004 to 2005, data from National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) 1 ã Documented at least 117,000 hospitalizations ã More than 700,000 ED visits ã More recent estimates are 130,000 hospitalizations and more than a million ED visits per year  2 ã  Adverse drug events -caused by (about a third each) 2 ã  Allergic reactions ã Non-allergic side effects ã Unintentional overdoses Medication-related Side Effects 1 Budnitz, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA . 2006 Oct 18;296(15):1858-66. 2 FDA’s Safe Use Initiative. http://www.fda.gov/downloads/Drugs/Drug Safety/UCM188961.pdf (accessed January 17, 2016) ã Click to edit Master text styles ã Second level ã Third level ãFourth level ãFifth level Click to edit
Recommended
View more...
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks